HFA Premium Access

Soluble suppression of tumorigenicity-2 in cardiac amyloidosis, hypertrophic and dilated cardiomyopathy

Congress Presentation

About the speaker

Doctor Vincenzo Castiglione

Sant'Anna School of Advanced Studies, Pisa (Italy)
2 presentations
0 follower

14 more presentations in this session

Multiple patterns of left ventricular diastolic function and its determinants in cardiac amyloidosis: an updated evaluation according to ASE/EACVI 2016 guidelines

Speaker: Doctor S. Oghina (Creteil, FR)

Thumbnail

High prevalence of cancer in patients with peripartum cardiomyopathy and potential pathophysiological connections

Speaker: Doctor T. Pfeffer (Hannover, DE)

Thumbnail

After initial improvement, left ventricular ejection fraction remains stable in long-term survivors with dilated cardiomyopathy

Speaker: Ms A. Knutsen (Nordbyhagen, NO)

Thumbnail

Clinical utility of the IMPACT score for mortality prediction after heart transplantation: external validation study.

Speaker: Doctor C. Ortiz-Bautista (Madrid, ES)

Thumbnail

Genetic risk prediction of atrial fibrillation in a contemporary heart failure cohort

Speaker: Miss M. Kloosterman (Groningen, NL)

Thumbnail

Access the full session

Rapid Fire 7 - Improving our insights: biomarkers, imaging, scores

Speakers: Doctor V. Castiglione, Doctor S. Oghina, Doctor T. Pfeffer, Ms A. Knutsen, Doctor C. Ortiz-Bautista...
Thumbnail

About the event

Image

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations